Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.80
Ask:
1.90
Spread: 0.10 (5.556%)
Market Cap: £2.18m
RDT Live PriceLast checked at - London Stock Exchange

Intraday Rosslyn Data Share Chart

Trading Update

19 Jun 2025 07:00

RNS Number : 4709N
Rosslyn Data Technologies PLC
19 June 2025
 

19 June 2025

 

Rosslyn Data Technologies plc

("Rosslyn" or the "Company")

 

Trading Update

Rosslyn to report strong growth for FY 2025 in line with market expectations

 

Rosslyn (AIM: RDT), the provider of a leading cloud-based spend intelligence platform, is pleased to provide the following update on trading for the year ended 30 April 2025 ("FY 2025") and the Company's outlook.

 

In line with market expectations and the Company's last trading update that was announced on 5 March 2025, the Company expects to report revenue growth for FY 2025 of c. 14% to £3.3m (FY 2024: £2.9m) and a significant improvement in adjusted EBITDA loss to £1.7m (FY 2024: £2.5m loss). Furthermore, the Company had cash and cash equivalents of c. £1.7m as at 30 April 2025 (30 April 2024: £0.6m), with cash burn rate significantly reduced to £142k per month (FY 2024: £218k).

 

The increase in revenue in FY 2025 reflects the contribution from development fees and also growth in professional services fees, the latter being for work undertaken to tailor the Company's solution to align with customers' infrastructure or meet specific additional solution requirements. Development fees are for additional bespoke development performed for the Company's major new client (the "Major New Client") that was won during the first half of FY 2025 and is a leading global technology company and household name.

 

The improvement in adjusted EBITDA reflects the increased contribution to revenue from professional services and development fees as well as the strategic decision to prioritise quality of revenues and not renew certain low-value or low-margin contracts. It also reflects a reduction in operating expenses due to lower employee-related costs following a restructuring in the prior year and lower rent costs following the closure of the Company's Portsmouth office.

 

The Company entered the current financial year to 30 April 2026 ("FY 2026") experiencing increased momentum compared with the same time in the prior year, and with a larger total and weighted pipeline. Rosslyn is in advanced negotiations with a number of potential new and existing customers regarding new contracts and is pleased to have already secured a three-year contract, worth £200k of revenue over the term of the contract, with a British train operating company, which is a new customer. With the expected conversion of the Company's pipeline as well as further planned development work for the Major New Client, the Company expects its monthly cash burn rate to be further reduced significantly over the course of the first half of FY 2026 and for it to become cash generative on a monthly basis by the end of FY 2026.

 

As previously announced, the Board has been prioritising sustainable growth, and it continues to do so. One of the outcomes from prioritising quality of revenues has been the Company's pipeline including customer profiles that are moving up the size spectrum. Commensurate with this, the timeline for conversion of some of these opportunities has taken longer than initially anticipated, including the rollout to other departments of the Major New Customer, and this is expected to continue into FY 2026.

 

Notwithstanding the impact on the Company's short-term growth rate, the Board believes that this approach will enable Rosslyn to generate maximum value for shareholders in the medium- to long-term. Accordingly, and with the Company having a clear path to delivering positive and sustainable growth for FY 2026, the Board looks to the future with confidence.

 

The Company will provide further detail in its full year results announcement.

 

 

Enquiries

 

Rosslyn

Paul Watts, Chief Executive Officer

James Appleby, Chairman

+44 (0)20 3285 8008

 

Cavendish Capital Markets Limited (Nominated adviser and Broker)

Stephen Keys/George Lawson

+44 (0)20 7220 0500

Gracechurch Group (Financial PR)

Claire Norbury/Anysia Virdi

++44 (0)20 4582 3500

 

 

About Rosslyn

 

Rosslyn (AIM: RDT) provides an award-winning spend intelligence and predictive analytics platform. The Rosslyn Platform helps organizations with diverse supply chains mitigate risk and make informed strategic decisions. It leverages automated workflows, artificial intelligence and machine learning to extract and consolidate procurement data providing visibility of complex supplier data, enabling supplier spend savings and delivering rapid ROI. For more information visit www.rosslyn.ai. Investors wishing to contact the Company should email investors@rosslyn.ai.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKFBDFBKDQAD
Date   Source Headline
20th Aug 20195:28 pmRNSHolding(s) in Company
25th Jul 20194:58 pmRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSContract Win
17th Jun 20193:04 pmRNSExercise of Options, Director/PDMR Shareholding
30th May 20192:53 pmRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSTrading Update
20th May 20197:00 amRNSBoard Changes
11th Apr 20197:00 amRNSBoard Appointment
9th Apr 20197:00 amRNSLoan Refinancing
25th Feb 20191:54 pmRNSHolding(s) in Company
11th Feb 20197:00 amRNSContract Wins
11th Dec 20183:46 pmRNSHolding(s) in Company
5th Dec 20183:25 pmRNSHolding(s) in Company
5th Dec 20183:23 pmRNSHolding(s) in Company
30th Nov 201812:38 pmRNSDirector/PDMR Shareholding
26th Nov 20187:00 amRNSHalf-year Report
7th Nov 20185:29 pmRNSResult of AGM
5th Nov 20188:08 amRNSHolding(s) in Company
30th Oct 20189:38 amRNSAGM Statement
30th Oct 20187:00 amRNSContract Win
19th Oct 201811:06 amRNSPosting of Annual Report and Registered Address
8th Oct 201810:36 amRNSHolding(s) in Company
5th Oct 201811:13 amRNSDirector/PDMR Shareholding
1st Oct 20188:24 amRNSFinal Results
27th Sep 201810:06 amRNSTrading Update
3rd Sep 20187:00 amRNSContract Win
25th Jul 201811:14 amRNSDirector/PDMR Dealing and Issue of Equity
23rd Jul 20187:00 amRNSBoard Appointment and Changes
16th Jul 20184:47 pmRNSHolding(s) in Company
3rd Jul 201812:25 pmRNSContract Win
26th Jun 20187:00 amRNSTrading Update
22nd May 20189:44 amRNSHolding(s) in Company
10th May 201811:07 amRNSHolding(s) in Company
3rd Apr 201811:15 amRNSHolding(s) in Company
28th Feb 201811:27 amRNSDirector/PDMR Shareholding
31st Jan 20187:00 amRNSHalf-year Report
28th Nov 20175:51 pmRNSHolding(s) in Company
2nd Nov 20178:29 amRNSHolding(s) in Company
17th Oct 20172:08 pmRNSPosting of Annual Report
27th Sep 20174:53 pmRNSDirector/PDMR Shareholding
15th Sep 20178:00 amRNSGrant of Options
31st Aug 20172:46 pmRNSDirector/PDMR Shareholding
30th Aug 20179:22 amRNSFinal Results
31st Jul 20177:00 amRNSContract Wins
12th Jul 20174:03 pmRNSHolding(s) in Company
17th May 20174:16 pmRNSHolding(s) in Company
16th May 20172:41 pmRNSDirector/PDMR Shareholding
16th May 201711:49 amRNSHolding(s) in Company
16th May 201711:46 amRNSHolding(s) in Company
15th May 20175:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.